PharmTech AI Pulse Check panelists explain why attribution, audit trails, and sign-off matter more than AI watermark detection for GxP quality teams.
|Articles|January 31, 2020
- Pharmaceutical Technology\'s In the Lab eNewsletter-02-05-2020
- Volume 15
- Issue 2
SP Scientific Launches HT Series 3i Evaporators
The evaporators are designed to boost evaporation and lyophilization results while remaining environmentally friendly and maintaining high-throughput and speed.
Advertisement
The updated HT Series 3i Evaporators from SP Scientific are designed to boost evaporation and lyophilization results while remaining environmentally friendly and maintaining high-throughput and speed.
According to a company press release, the evaporators include Dri-Pure anti-bumping technology to prevent foaming and bumping from causing cross-contamination and sample loss, while their dry vacuum pumps and -75-°C auto-defrost and draining condensers guarantee controlled evaporation of all sample types.
The evaporators come equipped with sample holders for tubes, vials, flasks, and 96 well plates, and space for hydrochloric acid resistance, inert gas purge, and exalt-controlled crystallization, making them well-matched to corrosive acids, explosive solvents, and common organic solvents. They also include touchscreen controls, automatic programming, and a new door actuator for error-free access.
SP Scientific announced the launch of the new evaporators on Jan. 6, 2020.
Source:
Articles in this issue
over 6 years ago
Antibody Development Made Easier with Synthetic Biologyover 6 years ago
Evonetix, imec Partner on Chip-Based Technology Scale-Upover 6 years ago
Daiichi Sankyo Licenses ERS Genomics’ CRISPR Gene Editing Techover 6 years ago
Otsuka, PhoreMost Team Up for Drug Discoveryover 6 years ago
Nicoya Introduces the First Digital Benchtop SPR Systemover 6 years ago
Vetter Combines Laboratory Portfolio into Single Sitealmost 7 years ago
Finding the Source of Quality ProblemsAdvertisement
Related to this article
Ron Scarboro, Azurity Pharmaceuticals, explains how cross-functional development, disciplined reformulation, and post-approval metrics can help proven medicines work in everyday use.
The FDA approves oral pritelivir for drug-resistant herpes sores in immunocompromised patients; what it means for antiviral development and manufacturing.
This week, drug formulation and manufacturing experts showcased their knowledge, and companies exhibited their products, at CPHI Milan.
FDA approves Teva’s Weltruza, a once-monthly subcutaneous olanzapine for schizophrenia whose copolymer depot eliminates post-injection monitoring.
Equivalence test using two one-sided tests are widely used for demonstrating the comparability of treatment effects in different research fields. The method described in the manuscript aims to use simulations in Microsoft Excel to compute power for 2 one-sided tests for two groups with unequal variances.
Richard Jaenisch examines whether FDA's NAM pathway truly shortens drug pipelines or just shifts the evidentiary burden elsewhere.
Susan J. Schniepp, distinguished fellow with Nelson Labs, and Siegfried Schmitt, PhD, vice president, Technical, with Parexel, clear up some of the confusion about what does and does not need to be complied with regarding standards set by international pharmacopoeias.
Advertisement
Advertisement